Literature DB >> 15329968

Extremely high body mass index is not a contraindication to laparoscopic gastric bypass.

Dominick Artuso1, Michael Wayne, Ashutosh Kaul, Moses Bairamian, Julio Teixeira, Thomas Cerabona.   

Abstract

BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGBP) is an effective operation for morbidly obese patients who have failed conservative weight loss treatments. It is currently indicated for patients with BMI >40 kg/m2 or >35 with significant co-morbidities. Controversy exists whether there is an upper limit to BMI beyond which this operation should not be performed.
METHODS: Between April 1999 and February 2001, 82 patients (19 male, 63 female) underwent LRYGBP. Average age was 43.6, and average BMI was 56 kg/m2. These patients were divided into those with BMI < 60 and those with BMI > or =60 kg/m2.
RESULTS: There were 61 patients with BMI < 60 and 21 patients with BMI > or =60. The groups were similar in age, gender, distribution or incidence of co-morbid conditions (diabetes, coronary artery disease, hypertension, sleep apnea, asthma) between the groups. The BMI > or =60 group had a significantly longer length of stay (6.6 days vs 5.3 days, P <0.05), and only 1 patient (BMI 85) developed an anastomotic leak and died. 2 patients in this group (BMI 62 and 73) developed small bowel obstruction requiring lysis of adhesions. 1 patient in the BMI < 60 group developed a gastrojejunal stricture requiring balloon dilatation.
CONCLUSION: While patients with a BMI > or =60 are at higher risk for postoperative complications, they are also at higher risk from continued extreme obesity. In our series, 85% of these patients had an uneventful postoperative course and began shedding excess weight. BMI > or =60 should not be a contraindication for LRYGBP.

Entities:  

Mesh:

Year:  2004        PMID: 15329968     DOI: 10.1381/0960892041590764

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  10 in total

1.  Perioperative Short-Term Outcome in Super-Super-Obese Patients Undergoing Bariatric Surgery.

Authors:  Anna Duprée; Alexander Tarek El Gammal; Stefan Wolter; Silvana Urbanek; Nina Sauer; Oliver Mann; Philipp Busch
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

2.  Duodenal switch provides superior weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass.

Authors:  Vivek N Prachand; Roy T Davee; John C Alverdy
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

3.  Factors Predicting Length of Stay Following Bariatric Surgery: Retrospective Review of a Single UK Tertiary Centre Experience.

Authors:  Fahad Mahmood; Alistair J Sharples; Adriana Rotundo; Nagammapudur Balaji; Vittal S R Rao
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

4.  Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass.

Authors:  Maria Dolores Frutos; Maria Dolores Morales; Juan Luján; Quiteria Hernández; Graciela Valero; Pascual Parrilla
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

5.  Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass.

Authors:  Vivek N Prachand; Marc Ward; John C Alverdy
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

6.  Is BMI greater than 60 kg/m(2) a predictor of higher morbidity after laparoscopic Roux-en-Y gastric bypass?

Authors:  L Kushnir; W J Dunnican; B Benedetto; W Wang; C Dolce; S Lopez; T P Singh
Journal:  Surg Endosc       Date:  2009-06-18       Impact factor: 4.584

7.  Non-transectional open gastric bypass as the definitive bariatric procedure for 61 patients with BMI of 70 and higher.

Authors:  Gus J Slotman
Journal:  Obes Surg       Date:  2009-10-14       Impact factor: 4.129

8.  LapBand System in super-superobese patients (>60 kg/m(2)): 4-year results.

Authors:  Fiore Torchia; Vincenza Mancuso; Simona Civitelli; Antonio Di Maro; Pasquale Cariello; Pasquale Tricarico Rosano; Giuseppe Ciriaco Sionne; Michele Lorenzo; Antonio J Cascardo
Journal:  Obes Surg       Date:  2008-11-20       Impact factor: 4.129

9.  Endoscopic Sleeve Gastroplasty (ESG) for High-Risk Patients, High Body Mass Index (> 50 kg/m2) Patients, and Contraindication to Abdominal Surgery.

Authors:  Renjie Li; Wilfried Veltzke-Schlieker; Andreas Adler; Maximilian Specht; Wael Eskander; Mahmoud Ismail; Harun Badakhshi; Manoel Passos Galvao; Ricardo Zorron
Journal:  Obes Surg       Date:  2021-04-27       Impact factor: 4.129

10.  Early outcome of bariatric surgery for the treatment of type 2 diabetes mellitus in super-obese Malaysian population.

Authors:  Reynu Rajan; Mohammed Sam-Aan; Nik Ritza Kosai; Mohamad Aznan Shuhaili; Tee Sze Chee; Ajay Venkateswaran; Kamal Mahawar
Journal:  J Minim Access Surg       Date:  2020 Jan-Mar       Impact factor: 1.407

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.